Related Experiment Videos
Catecholic flavonoids acting as telomerase inhibitors
Maria Menichincheri1, Dario Ballinari, Alberto Bargiotti
1Department of Chemistry, BU-Nerviano Medical Sciences, Viale Pasteur 10, 20014 Nerviano (MI), Italy. maria.menichincheri@nervianoms.com
Journal of Medicinal Chemistry
|December 14, 2004
Summary
Researchers discovered a new telomerase inhibitor, 7,8,3
Area of Science:
- Oncology
- Medicinal Chemistry
- Biochemistry
Background:
- Telomerase is a key target in oncology.
- Development of novel telomerase inhibitors is crucial for anticancer drug discovery.
Purpose of the Study:
- To identify novel telomerase inhibitors from polyhydroxylated flavonoids.
- To optimize lead compounds through medicinal chemistry for enhanced anticancer activity.
Main Methods:
- Focused screening of polyhydroxylated flavonoids.
- In vitro activity assessment using Flash-Plate and TRAP assays.
- Medicinal chemistry optimization and synthesis of structural analogues.
Main Results:
- Identified 7,8,3',4'-tetrahydroxyflavone as a potent telomerase inhibitor (IC50 = 0.2 microM).
- Developed new structural analogues with submicromolar potencies.
- Confirmed in vitro activity through validated assays.
Conclusions:
- 7,8,3',4'-tetrahydroxyflavone is a promising lead for anticancer drug development.
- Medicinal chemistry modifications successfully enhanced telomerase inhibitory activity.
- Optimized analogues represent potential new anticancer agents.